Refine
Has Fulltext
- yes (21)
Is part of the Bibliography
- yes (21)
Year of publication
Document Type
- Journal article (21)
Keywords
- ADHD (4)
- CXCR4 (2)
- breast cancer (2)
- predictive markers (2)
- AKT1 (1)
- Action potentials (1)
- Adult (1)
- Aggression (1)
- Antisocial behavior (1)
- Arabidopsis-thaliana (1)
- Association (1)
- BDNF (1)
- BRCA1 (1)
- Big Five (1)
- CDH13 (1)
- CML (1)
- COVID-19 (1)
- Conduct disorder (1)
- Covid-19 (1)
- DNA-repair (1)
- DNA-repair genes (1)
- Deficit/hyperactivity disorder (1)
- Diagnostic approach (1)
- Dionaea-muscipula ellis (1)
- EZH1 (1)
- EZH2 (1)
- GWAS (1)
- Gene (1)
- Genomics data sets (1)
- H3K27me3 (1)
- Human behaviour (1)
- Jasmonate perception (1)
- Kind (1)
- LASP1 (1)
- Large multicenter ADHD (1)
- Medizin (1)
- NAKO (1)
- PET (1)
- PTCL (1)
- Personalized medicine (1)
- Plant utricularia-gibba (1)
- Prognostic markers (1)
- Programmed cell-death (1)
- Psychiatric disorders (1)
- Psychische Entwicklung (1)
- RNA-SEQ data (1)
- Rating scale (1)
- SARS-CoV- 2 (1)
- Stress responses (1)
- Susceptibility loci (1)
- T-cell non-Hodgkin's lymphomas (1)
- Wonderful plants (1)
- [\(^{68}\)Ga] pentixafor (1)
- adult-onset (1)
- age at onset (1)
- agreeableness (1)
- anxiety (1)
- anxious depression (1)
- attention (1)
- autoimmune (1)
- cancer genomics (1)
- delivery mode (1)
- depressive disorder (1)
- epigenetics (1)
- executive functions (1)
- extracorporeal membrane oxygenation (ECMO) (1)
- extreme phenotypes (1)
- gene (1)
- genetic variants (1)
- glaucoma (1)
- hereditary breast and ovarian cancer (1)
- human behaviour (1)
- hyperactivity (1)
- immunohistochemistry (1)
- impulsivity (1)
- intensive care unit (1)
- late-onset (1)
- maternal (1)
- molecular neuroscience (1)
- neurodevelopment (1)
- neurotrophic factors (1)
- next generation sequencing (1)
- next-generation-sequencing (1)
- offspring (1)
- oncogenesis (1)
- osteoarthritis (1)
- paediatric cancer (1)
- panel sequencing (1)
- partial knee arthroplasty (1)
- paternal (1)
- patient-specific implant (1)
- patient-specific instruments (1)
- perinatal (1)
- personalized medicine (1)
- pharmacotherapy (1)
- pleural mesothelioma (1)
- polygenic risk score (1)
- postnatal depression (1)
- psychiatric disorders (1)
- rare mendelian disorders (1)
- sex (1)
- stroke (1)
- substance abuse disorder (1)
- survey (1)
- telemedicine (1)
- theranostics (1)
- therapy response (1)
- translational research (1)
- unicompartmental knee arthroplasty (1)
- venturesomeness (1)
- working memory (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (7)
- Institut für Psychologie (4)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Lehrstuhl für Molekulare Psychiatrie (3)
- Pathologisches Institut (3)
- Institut für Experimentelle Biomedizin (2)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Center for Computational and Theoretical Biology (1)
Sonstige beteiligte Institutionen
Pan-cancer analyses that examine commonalities and differences among various cancer types have emerged as a powerful way to obtain novel insights into cancer biology. Here we present a comprehensive analysis of genetic alterations in a pan-cancer cohort including 961 tumours from children, adolescents, and young adults, comprising 24 distinct molecular types of cancer. Using a standardized workflow, we identified marked differences in terms of mutation frequency and significantly mutated genes in comparison to previously analysed adult cancers. Genetic alterations in 149 putative cancer driver genes separate the tumours into two classes: small mutation and structural/copy-number variant (correlating with germline variants). Structural variants, hyperdiploidy, and chromothripsis are linked to TP53 mutation status and mutational signatures. Our data suggest that 7–8% of the children in this cohort carry an unambiguous predisposing germline variant and that nearly 50% of paediatric neoplasms harbour a potentially druggable event, which is highly relevant for the design of future clinical trials.